Note: The job is a remote job and is open to candidates in USA. Celea Therapeutics is a biotechnology company developing transformative treatments for serious respiratory diseases, including late-stage therapies for fibrotic lung diseases. The Clinical Trial Site Activation Lead will lead global clinical trial start-up activities from site feasibility and regulatory submissions through site initiation and enrollment readiness, while coordinating sponsors, CROs, sites, legal teams, and cross-functional stakeholders.
Responsibilities
- Lead the development and implementation of global site activation plans
- Oversee site identification, pre-study evaluations, and feasibility assessments to optimize site selection
- Facilitate the preparation, review, and tracking of regulatory and essential documents (e.g., FDA Form 1572, IRB/IEC packages, Informed Consent Form adaptations)
- Drive the negotiation of clinical trial agreements and site budgets in partnership with CRO, legal, and clinical stakeholders
- Track and report on start-up Key Performance Indicators (KPIs), proactively identify bottlenecks, and implement risk mitigation strategies to keep the study on schedule
- Serve as the primary point of contact for investigative sites, investigators, and clinical teams during the start-up phase, and lead and/or support cross-functional start-up project team meetings
- Ensure all start-up activities align with protocol requirements, sponsor expectations, standard operating procedures (SOPs), and prevailing global regulations, and ensure eTMF inspection readiness for start-up documentation
- Support site readiness for regulatory audits and inspections, contributing to Corrective and Preventive Action (CAPA) plans, if needed
- Mentor, train, and oversee junior site activation staff, as applicable
Skills
- Bachelor's degree in Life Sciences, Health Sciences, or a related field; equivalent experience considered
- Minimum of 4–6 years of relevant experience in clinical research, with a strong focus on clinical site start-up, regulatory submissions, or trial management
- Deep understanding of ICH-GCP guidelines, global regulatory requirements, and local ethics committee submissions
- Proven ability to manage multi-country or high-volume clinical study start-up activities and cross-functional teams, with exceptional negotiation, risk-resolution, and written/verbal communication skills
- Entrepreneurial mindset and comfort operating in a fast-paced, early-stage environment
- Proficiency using AI tools to work smarter — curiosity about how technology can improve the quality and speed of your work
- Familiarity with clinical trial technologies
- Experience supporting late-stage (Phase 3) global clinical trials
Benefits
- This position is hybrid or remote friendly.
- Play a pivotal role in advancing life-changing therapies for patients with devastating lung diseases.
- Shape the foundation of a Phase 3–ready biotech poised for significant growth.
- Collaborate with a passionate, mission-driven leadership team.
- Bonus and equity compensation.
Company Overview